Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.20819206 |
2 | synaptic vesicle maturation (GO:0016188) | 6.17346493 |
3 | locomotory exploration behavior (GO:0035641) | 6.00963079 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.74649713 |
5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.52327304 |
6 | vocalization behavior (GO:0071625) | 5.43921893 |
7 | synaptic vesicle exocytosis (GO:0016079) | 5.43832011 |
8 | glutamate secretion (GO:0014047) | 5.39406855 |
9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.33798019 |
10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.31297391 |
11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.96728188 |
12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.96419062 |
13 | protein localization to synapse (GO:0035418) | 4.70613190 |
14 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.64442493 |
15 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.53839620 |
16 | exploration behavior (GO:0035640) | 4.52082264 |
17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.49596616 |
18 | regulation of synapse structural plasticity (GO:0051823) | 4.46352146 |
19 | layer formation in cerebral cortex (GO:0021819) | 4.44777920 |
20 | regulation of synaptic vesicle transport (GO:1902803) | 4.43111087 |
21 | neurotransmitter secretion (GO:0007269) | 4.40284676 |
22 | neuronal action potential propagation (GO:0019227) | 4.38620319 |
23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.36650061 |
24 | dendritic spine morphogenesis (GO:0060997) | 4.27630757 |
25 | neuron cell-cell adhesion (GO:0007158) | 4.20470779 |
26 | synaptic transmission, glutamatergic (GO:0035249) | 4.13736227 |
27 | proline transport (GO:0015824) | 4.05609917 |
28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.03891754 |
29 | cellular potassium ion homeostasis (GO:0030007) | 3.98690940 |
30 | glutamate receptor signaling pathway (GO:0007215) | 3.95136581 |
31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93447368 |
32 | long-term memory (GO:0007616) | 3.93071381 |
33 | gamma-aminobutyric acid transport (GO:0015812) | 3.83643725 |
34 | neuron-neuron synaptic transmission (GO:0007270) | 3.83596539 |
35 | positive regulation of membrane potential (GO:0045838) | 3.81107720 |
36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.79382032 |
37 | positive regulation of synapse maturation (GO:0090129) | 3.75018266 |
38 | regulation of synaptic plasticity (GO:0048167) | 3.74873735 |
39 | sodium ion export (GO:0071436) | 3.74304350 |
40 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.70434373 |
41 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.66793321 |
42 | neuromuscular process controlling balance (GO:0050885) | 3.64155285 |
43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.58993663 |
44 | auditory behavior (GO:0031223) | 3.57957379 |
45 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.54797459 |
46 | long-term synaptic potentiation (GO:0060291) | 3.52298115 |
47 | neurotransmitter transport (GO:0006836) | 3.51530073 |
48 | activation of protein kinase A activity (GO:0034199) | 3.50219283 |
49 | L-amino acid import (GO:0043092) | 3.50042015 |
50 | response to auditory stimulus (GO:0010996) | 3.48421992 |
51 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.40213831 |
52 | cell communication by electrical coupling (GO:0010644) | 3.36484200 |
53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.35733317 |
54 | regulation of neurotransmitter secretion (GO:0046928) | 3.35535902 |
55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.33965522 |
56 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.33680907 |
57 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.33339360 |
58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.30580682 |
59 | postsynaptic membrane organization (GO:0001941) | 3.30512265 |
60 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.30432526 |
61 | synaptic vesicle endocytosis (GO:0048488) | 3.29754849 |
62 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.29038820 |
63 | regulation of neurotransmitter levels (GO:0001505) | 3.28084899 |
64 | prepulse inhibition (GO:0060134) | 3.26895208 |
65 | neuron recognition (GO:0008038) | 3.25994317 |
66 | dendritic spine organization (GO:0097061) | 3.25367279 |
67 | transmission of nerve impulse (GO:0019226) | 3.25063675 |
68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.24267467 |
69 | positive regulation of neurotransmitter transport (GO:0051590) | 3.22910338 |
70 | dendrite morphogenesis (GO:0048813) | 3.20762721 |
71 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.19893977 |
72 | regulation of vesicle fusion (GO:0031338) | 3.18927865 |
73 | neuromuscular process controlling posture (GO:0050884) | 3.18238323 |
74 | detection of calcium ion (GO:0005513) | 3.17225603 |
75 | cardiac muscle contraction (GO:0060048) | 3.16313727 |
76 | regulation of neurotransmitter transport (GO:0051588) | 3.14859787 |
77 | cardiac myofibril assembly (GO:0055003) | 3.14512722 |
78 | axonal fasciculation (GO:0007413) | 3.14448251 |
79 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.11762796 |
80 | regulation of dendritic spine development (GO:0060998) | 3.10275432 |
81 | innervation (GO:0060384) | 3.09801929 |
82 | positive regulation of synaptic transmission (GO:0050806) | 3.09023389 |
83 | response to histamine (GO:0034776) | 3.06297570 |
84 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.04645886 |
85 | positive regulation of dendritic spine development (GO:0060999) | 3.04136500 |
86 | cellular response to epinephrine stimulus (GO:0071872) | 3.03580182 |
87 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.02982090 |
88 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02610367 |
89 | membrane depolarization (GO:0051899) | 3.02566656 |
90 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.02494400 |
91 | learning (GO:0007612) | 3.01816455 |
92 | neuromuscular process (GO:0050905) | 3.00544874 |
93 | regulation of synaptic transmission (GO:0050804) | 3.00486771 |
94 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.99624332 |
95 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.99446673 |
96 | neuronal ion channel clustering (GO:0045161) | 2.97645371 |
97 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.96816714 |
98 | barbed-end actin filament capping (GO:0051016) | 2.96490538 |
99 | low-density lipoprotein particle clearance (GO:0034383) | 2.96301249 |
100 | regulation of cell communication by electrical coupling (GO:0010649) | 2.96102742 |
101 | membrane hyperpolarization (GO:0060081) | 2.94933384 |
102 | behavioral defense response (GO:0002209) | 2.94203021 |
103 | behavioral fear response (GO:0001662) | 2.94203021 |
104 | cerebellar granule cell differentiation (GO:0021707) | 2.92764241 |
105 | membrane depolarization during action potential (GO:0086010) | 2.91788246 |
106 | glycine transport (GO:0015816) | 2.91606881 |
107 | cell migration in hindbrain (GO:0021535) | 2.91408880 |
108 | amino acid import (GO:0043090) | 2.91084828 |
109 | vesicle transport along microtubule (GO:0047496) | 2.90156111 |
110 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.88756264 |
111 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.88714156 |
112 | social behavior (GO:0035176) | 2.88024391 |
113 | intraspecies interaction between organisms (GO:0051703) | 2.88024391 |
114 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.86366591 |
115 | muscle filament sliding (GO:0030049) | 2.84127106 |
116 | actin-myosin filament sliding (GO:0033275) | 2.84127106 |
117 | cell communication involved in cardiac conduction (GO:0086065) | 2.76807526 |
118 | regulation of actin filament-based movement (GO:1903115) | 2.73458625 |
119 | myofibril assembly (GO:0030239) | 2.73428591 |
120 | response to dietary excess (GO:0002021) | 2.72498833 |
121 | negative regulation of amino acid transport (GO:0051956) | 2.62585879 |
122 | response to epinephrine (GO:0071871) | 2.60523016 |
123 | regulation of cholesterol storage (GO:0010885) | 2.59323691 |
124 | protein heterotrimerization (GO:0070208) | 2.54663905 |
125 | cellular response to monoamine stimulus (GO:0071868) | 2.52595863 |
126 | cellular response to catecholamine stimulus (GO:0071870) | 2.52595863 |
127 | striated muscle contraction (GO:0006941) | 2.51179042 |
128 | regulation of sequestering of triglyceride (GO:0010889) | 2.49132849 |
129 | sarcomere organization (GO:0045214) | 2.49113656 |
130 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.48096877 |
131 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.48059399 |
132 | cardiac muscle hypertrophy (GO:0003300) | 2.47571959 |
133 | regulation of membrane repolarization (GO:0060306) | 2.43808208 |
134 | apoptotic cell clearance (GO:0043277) | 2.42456066 |
135 | regulation of the force of heart contraction (GO:0002026) | 2.41082557 |
136 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.39566913 |
137 | actin-mediated cell contraction (GO:0070252) | 2.39297384 |
138 | adhesion of symbiont to host cell (GO:0044650) | 2.38108647 |
139 | virion attachment to host cell (GO:0019062) | 2.38108647 |
140 | cGMP-mediated signaling (GO:0019934) | 2.38063537 |
141 | striated muscle hypertrophy (GO:0014897) | 2.35311633 |
142 | cell migration involved in heart development (GO:0060973) | 2.35017727 |
143 | stress fiber assembly (GO:0043149) | 2.33492025 |
144 | response to inactivity (GO:0014854) | 2.33426676 |
145 | membrane assembly (GO:0071709) | 2.32681171 |
146 | potassium ion homeostasis (GO:0055075) | 2.31054967 |
147 | acylglycerol catabolic process (GO:0046464) | 2.30004022 |
148 | neutral lipid catabolic process (GO:0046461) | 2.30004022 |
149 | triglyceride catabolic process (GO:0019433) | 2.29764762 |
150 | adenosine receptor signaling pathway (GO:0001973) | 2.27940757 |
151 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.27640773 |
152 | muscle hypertrophy in response to stress (GO:0003299) | 2.27640773 |
153 | cardiac muscle adaptation (GO:0014887) | 2.27640773 |
154 | regulation of striated muscle contraction (GO:0006942) | 2.26690118 |
155 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.26003262 |
156 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.26003262 |
157 | cAMP biosynthetic process (GO:0006171) | 2.23961500 |
158 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.22579297 |
159 | response to gravity (GO:0009629) | 2.21126404 |
160 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.19441110 |
161 | response to catecholamine (GO:0071869) | 2.18756471 |
162 | response to monoamine (GO:0071867) | 2.18756471 |
163 | potassium ion import (GO:0010107) | 2.17594284 |
164 | muscle cell cellular homeostasis (GO:0046716) | 2.14806125 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.69409546 |
2 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13312347 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.10640774 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02703773 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02234387 |
6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.81029580 |
7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.81029580 |
8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.80945970 |
9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74411938 |
10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.74139472 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68623231 |
12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.61295258 |
13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.60776186 |
14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54059142 |
15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53959418 |
16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51728135 |
17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48474790 |
18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48393534 |
19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.39163838 |
20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.28451364 |
21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27362949 |
22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26096370 |
23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23996457 |
24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20836132 |
25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17015532 |
26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15828036 |
27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11766254 |
28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07467808 |
29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03468566 |
30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.94407769 |
31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.92843254 |
32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91945783 |
33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91653501 |
34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.84091395 |
35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82728293 |
36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77652822 |
37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67400576 |
38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57948180 |
39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54401974 |
40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46556929 |
41 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.46212844 |
42 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.44854543 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44650738 |
44 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.41269584 |
45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40352657 |
46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.39701249 |
47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.39701249 |
48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39344232 |
49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37134195 |
50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34476422 |
51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32926725 |
52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30486337 |
53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30444795 |
54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29881362 |
55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27462995 |
56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26292802 |
57 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25160219 |
58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25072817 |
59 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.24669674 |
60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22539496 |
61 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22333506 |
62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21878624 |
63 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20228519 |
64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19981044 |
65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19484008 |
66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16932304 |
67 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14970416 |
68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13306290 |
69 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13209338 |
70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12579351 |
71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11459306 |
72 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11022639 |
73 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10606640 |
74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09327318 |
75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08719233 |
76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08577001 |
77 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08073869 |
78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07401017 |
79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07401017 |
80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07390327 |
81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05847003 |
82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05841382 |
83 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05350353 |
84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04336734 |
85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03434553 |
86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02660191 |
87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02535837 |
88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01932426 |
89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00091918 |
90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99890789 |
91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99808297 |
92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99566932 |
93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98949830 |
94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98508903 |
95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98221315 |
96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97495326 |
97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97463310 |
98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97147942 |
99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96712105 |
100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96682661 |
101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96476874 |
102 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96305639 |
103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96221231 |
104 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95854988 |
105 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95021015 |
106 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94245741 |
107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93915214 |
108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93713817 |
109 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93678592 |
110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92601881 |
111 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92186998 |
112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91458750 |
113 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.91215066 |
114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90569505 |
115 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90377023 |
116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90116861 |
117 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90101836 |
118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89465054 |
119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89280309 |
120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88968005 |
121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88784584 |
122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88575935 |
123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87465701 |
124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86785055 |
125 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85957313 |
126 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85554505 |
127 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83775646 |
128 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83337788 |
129 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83221213 |
130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82185547 |
131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82120542 |
132 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.81283773 |
133 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.80738241 |
134 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.80608651 |
135 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80492243 |
136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80246873 |
137 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79747638 |
138 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79574899 |
139 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.79068574 |
140 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.77521654 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.97418137 |
2 | MP0003880_abnormal_central_pattern | 4.50063860 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.17535865 |
4 | MP0004270_analgesia | 3.81564762 |
5 | MP0002063_abnormal_learning/memory/cond | 3.39872757 |
6 | MP0009745_abnormal_behavioral_response | 3.32740842 |
7 | MP0008438_abnormal_cutaneous_collagen | 3.11301349 |
8 | MP0002064_seizures | 3.11276610 |
9 | MP0002822_catalepsy | 3.04834179 |
10 | MP0001968_abnormal_touch/_nociception | 2.98388556 |
11 | MP0009046_muscle_twitch | 2.93654008 |
12 | MP0002572_abnormal_emotion/affect_behav | 2.79813989 |
13 | MP0005423_abnormal_somatic_nervous | 2.69477870 |
14 | MP0002734_abnormal_mechanical_nocicepti | 2.61128515 |
15 | MP0000749_muscle_degeneration | 2.56275714 |
16 | MP0001486_abnormal_startle_reflex | 2.53893457 |
17 | MP0003279_aneurysm | 2.53731390 |
18 | MP0004130_abnormal_muscle_cell | 2.42671178 |
19 | MP0002272_abnormal_nervous_system | 2.42056502 |
20 | MP0009780_abnormal_chondrocyte_physiolo | 2.41947615 |
21 | MP0004858_abnormal_nervous_system | 2.37818986 |
22 | MP0005670_abnormal_white_adipose | 2.34347809 |
23 | MP0002736_abnormal_nociception_after | 2.24247255 |
24 | MP0001501_abnormal_sleep_pattern | 2.17231290 |
25 | MP0004084_abnormal_cardiac_muscle | 2.17226150 |
26 | MP0003705_abnormal_hypodermis_morpholog | 2.11956173 |
27 | MP0001958_emphysema | 2.08773740 |
28 | MP0002733_abnormal_thermal_nociception | 2.07552250 |
29 | MP0001440_abnormal_grooming_behavior | 2.02509781 |
30 | MP0002735_abnormal_chemical_nociception | 1.97717923 |
31 | MP0001970_abnormal_pain_threshold | 1.97448892 |
32 | MP0008569_lethality_at_weaning | 1.91519279 |
33 | MP0002909_abnormal_adrenal_gland | 1.89608529 |
34 | MP0003329_amyloid_beta_deposits | 1.89033485 |
35 | MP0003950_abnormal_plasma_membrane | 1.88747055 |
36 | MP0004036_abnormal_muscle_relaxation | 1.84955419 |
37 | MP0002837_dystrophic_cardiac_calcinosis | 1.82172064 |
38 | MP0002067_abnormal_sensory_capabilities | 1.82088054 |
39 | MP0000778_abnormal_nervous_system | 1.81277436 |
40 | MP0004811_abnormal_neuron_physiology | 1.79108460 |
41 | MP0004510_myositis | 1.76816426 |
42 | MP0002557_abnormal_social/conspecific_i | 1.75374248 |
43 | MP0004885_abnormal_endolymph | 1.70822708 |
44 | MP0005646_abnormal_pituitary_gland | 1.70236048 |
45 | MP0005503_abnormal_tendon_morphology | 1.70054344 |
46 | MP0005386_behavior/neurological_phenoty | 1.67766382 |
47 | MP0004924_abnormal_behavior | 1.67766382 |
48 | MP0002184_abnormal_innervation | 1.63413343 |
49 | MP0005058_abnormal_lysosome_morphology | 1.63249046 |
50 | MP0003879_abnormal_hair_cell | 1.59751919 |
51 | MP0004087_abnormal_muscle_fiber | 1.57549308 |
52 | MP0002972_abnormal_cardiac_muscle | 1.55592969 |
53 | MP0000955_abnormal_spinal_cord | 1.53853946 |
54 | MP0000343_altered_response_to | 1.53767506 |
55 | MP0000747_muscle_weakness | 1.51955873 |
56 | MP0002971_abnormal_brown_adipose | 1.50747184 |
57 | MP0000759_abnormal_skeletal_muscle | 1.48508119 |
58 | MP0005620_abnormal_muscle_contractility | 1.48158773 |
59 | MP0003633_abnormal_nervous_system | 1.44595517 |
60 | MP0005666_abnormal_adipose_tissue | 1.43295507 |
61 | MP0005275_abnormal_skin_tensile | 1.40236088 |
62 | MP0002882_abnormal_neuron_morphology | 1.38821760 |
63 | MP0003828_pulmonary_edema | 1.38624451 |
64 | MP0002066_abnormal_motor_capabilities/c | 1.37294444 |
65 | MP0001542_abnormal_bone_strength | 1.35466317 |
66 | MP0001984_abnormal_olfaction | 1.35299410 |
67 | MP0005595_abnormal_vascular_smooth | 1.31615215 |
68 | MP0000750_abnormal_muscle_regeneration | 1.29952413 |
69 | MP0009840_abnormal_foam_cell | 1.29480466 |
70 | MP0006138_congestive_heart_failure | 1.27851237 |
71 | MP0001502_abnormal_circadian_rhythm | 1.24586730 |
72 | MP0003787_abnormal_imprinting | 1.24446676 |
73 | MP0002295_abnormal_pulmonary_circulatio | 1.23149099 |
74 | MP0005645_abnormal_hypothalamus_physiol | 1.21853732 |
75 | MP0005375_adipose_tissue_phenotype | 1.21432244 |
76 | MP0003631_nervous_system_phenotype | 1.20077788 |
77 | MP0000767_abnormal_smooth_muscle | 1.19689145 |
78 | MP0004272_abnormal_basement_membrane | 1.17547412 |
79 | MP0005623_abnormal_meninges_morphology | 1.16627531 |
80 | MP0003283_abnormal_digestive_organ | 1.15268284 |
81 | MP0002152_abnormal_brain_morphology | 1.14359455 |
82 | MP0006276_abnormal_autonomic_nervous | 1.14039016 |
83 | MP0003191_abnormal_cellular_cholesterol | 1.12630744 |
84 | MP0002269_muscular_atrophy | 1.12528281 |
85 | MP0000569_abnormal_digit_pigmentation | 1.12044667 |
86 | MP0003075_altered_response_to | 1.11477960 |
87 | MP0001905_abnormal_dopamine_level | 1.11115678 |
88 | MP0009384_cardiac_valve_regurgitation | 1.09259897 |
89 | MP0005385_cardiovascular_system_phenoty | 1.08285973 |
90 | MP0001544_abnormal_cardiovascular_syste | 1.08285973 |
91 | MP0002108_abnormal_muscle_morphology | 1.07660764 |
92 | MP0003690_abnormal_glial_cell | 1.06111248 |
93 | MP0003091_abnormal_cell_migration | 1.05789012 |
94 | MP0003634_abnormal_glial_cell | 1.05159626 |
95 | MP0005165_increased_susceptibility_to | 1.05098682 |
96 | MP0005330_cardiomyopathy | 1.03686566 |
97 | MP0000751_myopathy | 1.01802842 |
98 | MP0002106_abnormal_muscle_physiology | 1.00905189 |
99 | MP0004142_abnormal_muscle_tone | 0.99946175 |
100 | MP0000013_abnormal_adipose_tissue | 0.97711898 |
101 | MP0001177_atelectasis | 0.96149057 |
102 | MP0001529_abnormal_vocalization | 0.95253087 |
103 | MP0002896_abnormal_bone_mineralization | 0.94599235 |
104 | MP0005369_muscle_phenotype | 0.94199402 |
105 | MP0008872_abnormal_physiological_respon | 0.94159381 |
106 | MP0003122_maternal_imprinting | 0.93831975 |
107 | MP0010386_abnormal_urinary_bladder | 0.93775178 |
108 | MP0002069_abnormal_eating/drinking_beha | 0.91551341 |
109 | MP0005257_abnormal_intraocular_pressure | 0.91141395 |
110 | MP0000733_abnormal_muscle_development | 0.89124540 |
111 | MP0008874_decreased_physiological_sensi | 0.85039850 |
112 | MP0003632_abnormal_nervous_system | 0.84950321 |
113 | MP0002332_abnormal_exercise_endurance | 0.84768560 |
114 | MP0001188_hyperpigmentation | 0.83244100 |
115 | MP0010630_abnormal_cardiac_muscle | 0.82849729 |
116 | MP0005388_respiratory_system_phenotype | 0.81975868 |
117 | MP0002133_abnormal_respiratory_system | 0.81975868 |
118 | MP0003566_abnormal_cell_adhesion | 0.81790565 |
119 | MP0000003_abnormal_adipose_tissue | 0.81551238 |
120 | MP0002229_neurodegeneration | 0.81531575 |
121 | MP0005167_abnormal_blood-brain_barrier | 0.81321241 |
122 | MP0001963_abnormal_hearing_physiology | 0.76685839 |
123 | MP0002090_abnormal_vision | 0.75977606 |
124 | MP0000604_amyloidosis | 0.75752474 |
125 | MP0002653_abnormal_ependyma_morphology | 0.74826887 |
126 | MP0004085_abnormal_heartbeat | 0.74820442 |
127 | MP0000631_abnormal_neuroendocrine_gland | 0.74730931 |
128 | MP0005499_abnormal_olfactory_system | 0.73726631 |
129 | MP0005394_taste/olfaction_phenotype | 0.73726631 |
130 | MP0004145_abnormal_muscle_electrophysio | 0.71657179 |
131 | MP0005551_abnormal_eye_electrophysiolog | 0.71304846 |
132 | MP0000920_abnormal_myelination | 0.70206725 |
133 | MP0001485_abnormal_pinna_reflex | 0.69754975 |
134 | MP0004233_abnormal_muscle_weight | 0.69423984 |
135 | MP0005535_abnormal_body_temperature | 0.69183256 |
136 | MP0001299_abnormal_eye_distance/ | 0.68641468 |
137 | MP0008961_abnormal_basal_metabolism | 0.65486298 |
138 | MP0002752_abnormal_somatic_nervous | 0.64877696 |
139 | MP0003045_fibrosis | 0.62155267 |
140 | MP0003861_abnormal_nervous_system | 0.61656658 |
141 | MP0004742_abnormal_vestibular_system | 0.60931073 |
142 | MP0001943_abnormal_respiration | 0.58985295 |
143 | MP0003137_abnormal_impulse_conducting | 0.57819727 |
144 | MP0004043_abnormal_pH_regulation | 0.56444064 |
145 | MP0003172_abnormal_lysosome_physiology | 0.55792959 |
146 | MP0002089_abnormal_postnatal_growth/wei | 0.55598667 |
147 | MP0000534_abnormal_ureter_morphology | 0.53687023 |
148 | MP0002638_abnormal_pupillary_reflex | 0.53443985 |
149 | MP0004484_altered_response_of | 0.52496172 |
150 | MP0001664_abnormal_digestion | 0.52415193 |
151 | MP0010769_abnormal_survival | 0.51658209 |
152 | MP0004215_abnormal_myocardial_fiber | 0.51095553 |
153 | MP0010768_mortality/aging | 0.47736557 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.36461139 |
2 | Myokymia (HP:0002411) | 7.08873117 |
3 | Focal seizures (HP:0007359) | 5.51790918 |
4 | Visual hallucinations (HP:0002367) | 4.84752053 |
5 | Epileptic encephalopathy (HP:0200134) | 4.78764703 |
6 | Action tremor (HP:0002345) | 4.27524799 |
7 | Atonic seizures (HP:0010819) | 4.24207536 |
8 | Progressive cerebellar ataxia (HP:0002073) | 3.95657181 |
9 | Febrile seizures (HP:0002373) | 3.91995293 |
10 | Absence seizures (HP:0002121) | 3.89422931 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 3.74811562 |
12 | Protrusio acetabuli (HP:0003179) | 3.72731044 |
13 | Sudden death (HP:0001699) | 3.72237154 |
14 | Dialeptic seizures (HP:0011146) | 3.59394503 |
15 | Type 1 muscle fiber predominance (HP:0003803) | 3.50839020 |
16 | Hyporeflexia of lower limbs (HP:0002600) | 3.45886320 |
17 | Ankle clonus (HP:0011448) | 3.44144818 |
18 | Supranuclear gaze palsy (HP:0000605) | 3.28926838 |
19 | Megalencephaly (HP:0001355) | 3.24755997 |
20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.24309567 |
21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.24309567 |
22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.24309567 |
23 | Broad-based gait (HP:0002136) | 3.21412705 |
24 | Depression (HP:0000716) | 3.20029395 |
25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.18827136 |
26 | Asymmetric septal hypertrophy (HP:0001670) | 3.17357712 |
27 | Dysdiadochokinesis (HP:0002075) | 3.14769220 |
28 | Poor eye contact (HP:0000817) | 3.14062729 |
29 | Premature rupture of membranes (HP:0001788) | 3.11253273 |
30 | Muscle fiber splitting (HP:0003555) | 3.10470253 |
31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.06179469 |
32 | Gaze-evoked nystagmus (HP:0000640) | 2.96327845 |
33 | Hyperventilation (HP:0002883) | 2.95718514 |
34 | Abnormal eating behavior (HP:0100738) | 2.94878125 |
35 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.94745433 |
36 | Papilledema (HP:0001085) | 2.93213070 |
37 | Abnormal social behavior (HP:0012433) | 2.88984328 |
38 | Impaired social interactions (HP:0000735) | 2.88984328 |
39 | Amblyopia (HP:0000646) | 2.83563371 |
40 | Atrial fibrillation (HP:0005110) | 2.82121080 |
41 | Anxiety (HP:0000739) | 2.81078243 |
42 | Distal lower limb muscle weakness (HP:0009053) | 2.80715805 |
43 | Gowers sign (HP:0003391) | 2.78515974 |
44 | Genetic anticipation (HP:0003743) | 2.78440479 |
45 | Dysmetria (HP:0001310) | 2.78125970 |
46 | Truncal ataxia (HP:0002078) | 2.76532736 |
47 | Hemiparesis (HP:0001269) | 2.73702612 |
48 | Abnormality of the lower motor neuron (HP:0002366) | 2.73581267 |
49 | Torticollis (HP:0000473) | 2.71975210 |
50 | Postural instability (HP:0002172) | 2.71880513 |
51 | Mutism (HP:0002300) | 2.71385738 |
52 | Annular pancreas (HP:0001734) | 2.65861212 |
53 | Primary atrial arrhythmia (HP:0001692) | 2.65134181 |
54 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60559042 |
55 | Urinary urgency (HP:0000012) | 2.58260851 |
56 | Abnormal atrioventricular conduction (HP:0005150) | 2.58231693 |
57 | Hemiplegia (HP:0002301) | 2.57895598 |
58 | Heart block (HP:0012722) | 2.57240753 |
59 | Popliteal pterygium (HP:0009756) | 2.56750459 |
60 | Aortic aneurysm (HP:0004942) | 2.54434842 |
61 | Supraventricular tachycardia (HP:0004755) | 2.54301320 |
62 | Abnormality of the calf musculature (HP:0001430) | 2.53193957 |
63 | Akinesia (HP:0002304) | 2.52888761 |
64 | Supraventricular arrhythmia (HP:0005115) | 2.51748879 |
65 | Insidious onset (HP:0003587) | 2.48872381 |
66 | Termporal pattern (HP:0011008) | 2.48872381 |
67 | Focal dystonia (HP:0004373) | 2.48791692 |
68 | Aplasia of the phalanges of the hand (HP:0009802) | 2.48786341 |
69 | Aplasia involving bones of the extremities (HP:0009825) | 2.48786341 |
70 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.48786341 |
71 | Stereotypic behavior (HP:0000733) | 2.48117602 |
72 | Vascular tortuosity (HP:0004948) | 2.47976812 |
73 | Excessive salivation (HP:0003781) | 2.46870847 |
74 | Drooling (HP:0002307) | 2.46870847 |
75 | Impaired smooth pursuit (HP:0007772) | 2.46434732 |
76 | Lipoatrophy (HP:0100578) | 2.44898646 |
77 | Nemaline bodies (HP:0003798) | 2.43838414 |
78 | Atrioventricular block (HP:0001678) | 2.43792532 |
79 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.43647790 |
80 | Cerebral aneurysm (HP:0004944) | 2.42934587 |
81 | Abnormality of binocular vision (HP:0011514) | 2.40914161 |
82 | Diplopia (HP:0000651) | 2.40914161 |
83 | Neurofibrillary tangles (HP:0002185) | 2.40176262 |
84 | Intention tremor (HP:0002080) | 2.36905817 |
85 | Cerebral inclusion bodies (HP:0100314) | 2.36888165 |
86 | Bradykinesia (HP:0002067) | 2.36678987 |
87 | Syncope (HP:0001279) | 2.33754017 |
88 | Axonal loss (HP:0003447) | 2.32845649 |
89 | Prolonged QT interval (HP:0001657) | 2.32688629 |
90 | Muscle fiber inclusion bodies (HP:0100299) | 2.30003081 |
91 | Aortic dissection (HP:0002647) | 2.29934641 |
92 | Aplasia of the musculature (HP:0100854) | 2.28744899 |
93 | Spinal rigidity (HP:0003306) | 2.28185826 |
94 | Status epilepticus (HP:0002133) | 2.25862208 |
95 | Hypoplastic heart (HP:0001961) | 2.24344426 |
96 | Arterial tortuosity (HP:0005116) | 2.23820065 |
97 | Spastic gait (HP:0002064) | 2.23104460 |
98 | Epileptiform EEG discharges (HP:0011182) | 2.22886223 |
99 | Round ear (HP:0100830) | 2.21927436 |
100 | Pointed chin (HP:0000307) | 2.21614215 |
101 | Obstructive sleep apnea (HP:0002870) | 2.21171488 |
102 | Impaired vibratory sensation (HP:0002495) | 2.20277127 |
103 | Craniofacial dystonia (HP:0012179) | 2.18115242 |
104 | Difficulty running (HP:0009046) | 2.17022638 |
105 | Dysmetric saccades (HP:0000641) | 2.16685366 |
106 | EMG: myopathic abnormalities (HP:0003458) | 2.15852059 |
107 | Progressive inability to walk (HP:0002505) | 2.15623021 |
108 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.15109829 |
109 | Lower limb muscle weakness (HP:0007340) | 2.14164459 |
110 | Dysostosis multiplex (HP:0000943) | 2.13806039 |
111 | EEG with generalized epileptiform discharges (HP:0011198) | 2.12746727 |
112 | Vertebral compression fractures (HP:0002953) | 2.12403776 |
113 | Ventricular arrhythmia (HP:0004308) | 2.11164669 |
114 | Bulbar palsy (HP:0001283) | 2.11001596 |
115 | Fetal akinesia sequence (HP:0001989) | 2.10084520 |
116 | Ventricular fibrillation (HP:0001663) | 2.07340588 |
117 | Scanning speech (HP:0002168) | 2.04780222 |
118 | Hypsarrhythmia (HP:0002521) | 2.03620046 |
119 | Fatigable weakness (HP:0003473) | 2.02851775 |
120 | Abnormality of the neuromuscular junction (HP:0003398) | 2.02851775 |
121 | Nuclear cataract (HP:0100018) | 2.02186220 |
122 | Bladder diverticulum (HP:0000015) | 2.01631207 |
123 | Exercise-induced myalgia (HP:0003738) | 2.01561331 |
124 | Frequent falls (HP:0002359) | 2.00938232 |
125 | Limb dystonia (HP:0002451) | 2.00255650 |
126 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00175469 |
127 | Absent speech (HP:0001344) | 2.00051527 |
128 | Bradycardia (HP:0001662) | 1.99762573 |
129 | Neck muscle weakness (HP:0000467) | 1.99670308 |
130 | Weak cry (HP:0001612) | 1.98990740 |
131 | Calf muscle hypertrophy (HP:0008981) | 1.96616511 |
132 | Pheochromocytoma (HP:0002666) | 1.96000927 |
133 | Skin nodule (HP:0200036) | 1.94448132 |
134 | Foot dorsiflexor weakness (HP:0009027) | 1.93920209 |
135 | Bundle branch block (HP:0011710) | 1.93176496 |
136 | Polyphagia (HP:0002591) | 1.92953877 |
137 | Insomnia (HP:0100785) | 1.92894003 |
138 | Diminished motivation (HP:0000745) | 1.92411677 |
139 | Lower limb amyotrophy (HP:0007210) | 1.91343694 |
140 | Lower limb asymmetry (HP:0100559) | 1.89751890 |
141 | Type 2 muscle fiber atrophy (HP:0003554) | 1.89444290 |
142 | Increased connective tissue (HP:0009025) | 1.89266157 |
143 | Generalized myoclonic seizures (HP:0002123) | 1.89088140 |
144 | Abnormality of the foot musculature (HP:0001436) | 1.88684937 |
145 | Incomplete penetrance (HP:0003829) | 1.88053071 |
146 | Thin ribs (HP:0000883) | 1.88034827 |
147 | Resting tremor (HP:0002322) | 1.85082411 |
148 | Gait ataxia (HP:0002066) | 1.84914577 |
149 | Mitral regurgitation (HP:0001653) | 1.84890684 |
150 | Ankle contracture (HP:0006466) | 1.83457735 |
151 | Ankyloglossia (HP:0010296) | 1.83197935 |
152 | Scapular winging (HP:0003691) | 1.82223607 |
153 | Overgrowth (HP:0001548) | 1.82199772 |
154 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82119737 |
155 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82119737 |
156 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82119737 |
157 | Hypoventilation (HP:0002791) | 1.79657063 |
158 | Infantile muscular hypotonia (HP:0008947) | 1.79520654 |
159 | Postural tremor (HP:0002174) | 1.78424941 |
160 | Mucopolysacchariduria (HP:0008155) | 1.78013644 |
161 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78013644 |
162 | Abnormality of the periventricular white matter (HP:0002518) | 1.77614829 |
163 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.77518945 |
164 | Apathy (HP:0000741) | 1.76802573 |
165 | Neuronal loss in central nervous system (HP:0002529) | 1.75119347 |
166 | Agitation (HP:0000713) | 1.73625490 |
167 | Clonus (HP:0002169) | 1.71416665 |
168 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.71224852 |
169 | Bronchomalacia (HP:0002780) | 1.70496378 |
170 | Abnormal EKG (HP:0003115) | 1.67426750 |
171 | Rapidly progressive (HP:0003678) | 1.67388393 |
172 | Abnormality of the corticospinal tract (HP:0002492) | 1.67049553 |
173 | Amyotrophic lateral sclerosis (HP:0007354) | 1.66820457 |
174 | Inability to walk (HP:0002540) | 1.66811516 |
175 | Rigidity (HP:0002063) | 1.66639190 |
176 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.65774294 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.98754856 |
2 | NTRK3 | 4.20401671 |
3 | MAP3K9 | 3.82701829 |
4 | PRKD3 | 2.93328921 |
5 | MARK1 | 2.88844810 |
6 | DAPK2 | 2.82149614 |
7 | MAP3K4 | 2.71196818 |
8 | MINK1 | 2.59828499 |
9 | MUSK | 2.56847771 |
10 | MYLK | 2.44723265 |
11 | PAK6 | 2.36509769 |
12 | KSR2 | 2.24457557 |
13 | MAP2K7 | 2.15978115 |
14 | NTRK2 | 2.15160729 |
15 | CAMKK1 | 2.05610006 |
16 | NTRK1 | 2.03822061 |
17 | LIMK1 | 1.97753175 |
18 | TTN | 1.90494994 |
19 | DAPK1 | 1.69116885 |
20 | KSR1 | 1.62399064 |
21 | CASK | 1.61331564 |
22 | PRPF4B | 1.60936074 |
23 | RIPK4 | 1.60326307 |
24 | OBSCN | 1.58453743 |
25 | CDK5 | 1.56875023 |
26 | MAP2K4 | 1.55354813 |
27 | TESK1 | 1.55077123 |
28 | ARAF | 1.53536464 |
29 | PLK2 | 1.49179424 |
30 | TGFBR2 | 1.48413401 |
31 | MAP3K12 | 1.45310293 |
32 | GRK7 | 1.44613117 |
33 | STK38 | 1.43040009 |
34 | MAPK12 | 1.41284218 |
35 | TYRO3 | 1.40522623 |
36 | GRK5 | 1.36067970 |
37 | MAP3K2 | 1.32246281 |
38 | TNIK | 1.30029175 |
39 | NEK9 | 1.21835055 |
40 | PRKCG | 1.20512577 |
41 | CDK19 | 1.18760630 |
42 | LATS2 | 1.15041840 |
43 | SIK2 | 1.14877809 |
44 | ABL2 | 1.14578769 |
45 | TAOK1 | 1.13839967 |
46 | MAPK13 | 1.13808707 |
47 | EPHB2 | 1.06892011 |
48 | CAMKK2 | 1.05916393 |
49 | ROCK1 | 1.03672760 |
50 | PHKG1 | 1.01575818 |
51 | PHKG2 | 1.01575818 |
52 | SGK494 | 0.98754785 |
53 | SGK223 | 0.98754785 |
54 | PNCK | 0.97762996 |
55 | UHMK1 | 0.97729896 |
56 | PKN1 | 0.97677913 |
57 | CDK18 | 0.95145618 |
58 | CDK15 | 0.94280505 |
59 | DDR2 | 0.92867964 |
60 | LMTK2 | 0.92698476 |
61 | CDK14 | 0.92415134 |
62 | MAP3K13 | 0.92235511 |
63 | SGK2 | 0.89713578 |
64 | FES | 0.88126862 |
65 | CAMK2A | 0.88050256 |
66 | PINK1 | 0.87931945 |
67 | STK11 | 0.87721685 |
68 | PAK2 | 0.86901174 |
69 | ALK | 0.85326936 |
70 | PRKCH | 0.84771634 |
71 | RET | 0.84541245 |
72 | CAMK1G | 0.83877884 |
73 | SGK3 | 0.83511493 |
74 | PTK2B | 0.82370290 |
75 | CAMK1 | 0.82183860 |
76 | MAPK4 | 0.82100518 |
77 | CDK11A | 0.81387761 |
78 | PAK3 | 0.80815244 |
79 | RAF1 | 0.78930721 |
80 | TAOK2 | 0.77214503 |
81 | CAMK1D | 0.72448720 |
82 | PDGFRB | 0.70231638 |
83 | PTK2 | 0.68982507 |
84 | CAMK2B | 0.68475214 |
85 | SGK1 | 0.67506220 |
86 | NEK1 | 0.67131531 |
87 | PDPK1 | 0.65869922 |
88 | PDK1 | 0.65566148 |
89 | AKT3 | 0.65268951 |
90 | BMPR2 | 0.65148516 |
91 | PIK3CG | 0.64438849 |
92 | MAP3K5 | 0.63840197 |
93 | RPS6KA2 | 0.62149790 |
94 | PRKD1 | 0.61895735 |
95 | TRIB3 | 0.61518607 |
96 | RIPK1 | 0.59717841 |
97 | MAPK7 | 0.57934928 |
98 | DYRK1A | 0.56341146 |
99 | CDC42BPA | 0.54141795 |
100 | PRKCZ | 0.52902054 |
101 | MARK2 | 0.51339905 |
102 | DAPK3 | 0.50788122 |
103 | MAP3K1 | 0.50586569 |
104 | MAP2K1 | 0.50130215 |
105 | RPS6KA3 | 0.49780815 |
106 | PRKG1 | 0.49471301 |
107 | MAP3K11 | 0.49422431 |
108 | DMPK | 0.49001509 |
109 | FER | 0.48142749 |
110 | IRAK3 | 0.48141861 |
111 | BRSK1 | 0.47324729 |
112 | PRKCE | 0.47305138 |
113 | TNK2 | 0.47207167 |
114 | OXSR1 | 0.47061173 |
115 | PDK2 | 0.47027379 |
116 | CSNK1G2 | 0.46070653 |
117 | MAPK10 | 0.45415245 |
118 | MAP3K6 | 0.45222539 |
119 | PRKAA2 | 0.45028425 |
120 | WNK1 | 0.44004428 |
121 | CAMK4 | 0.43296557 |
122 | PIM2 | 0.43067106 |
123 | NME1 | 0.42911340 |
124 | PDGFRA | 0.41677330 |
125 | NEK6 | 0.41222988 |
126 | PRKD2 | 0.40795097 |
127 | BMX | 0.40653411 |
128 | FGR | 0.40247788 |
129 | CAMK2G | 0.38725369 |
130 | BRAF | 0.38381499 |
131 | CAMK2D | 0.36403389 |
132 | SCYL2 | 0.36152094 |
133 | FYN | 0.35719991 |
134 | MOS | 0.33728518 |
135 | ROCK2 | 0.31921129 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.33272901 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.20790326 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.77540642 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60686452 |
5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.59226787 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.56119120 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48746624 |
8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43886563 |
9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.41236926 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.32878047 |
11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30102187 |
12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.28993777 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 2.12621849 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08317593 |
15 | Insulin secretion_Homo sapiens_hsa04911 | 2.05196904 |
16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.89796069 |
17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.87013928 |
18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.86929452 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70659581 |
20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65410674 |
21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65349923 |
22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63700284 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.58215322 |
24 | Long-term depression_Homo sapiens_hsa04730 | 1.57134722 |
25 | Taste transduction_Homo sapiens_hsa04742 | 1.52365653 |
26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50827057 |
27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46541493 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46509793 |
29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42054255 |
30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41305314 |
31 | Gap junction_Homo sapiens_hsa04540 | 1.37314475 |
32 | Lysosome_Homo sapiens_hsa04142 | 1.34624870 |
33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33253640 |
34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28612385 |
35 | Glioma_Homo sapiens_hsa05214 | 1.28236480 |
36 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26915136 |
37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25596021 |
38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.23843790 |
39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23778238 |
40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21537740 |
41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17328455 |
42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14922800 |
43 | Focal adhesion_Homo sapiens_hsa04510 | 1.14659596 |
44 | Melanogenesis_Homo sapiens_hsa04916 | 1.12524372 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11385730 |
46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10495537 |
47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10041885 |
48 | Axon guidance_Homo sapiens_hsa04360 | 1.08428348 |
49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07661347 |
50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02573843 |
51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98709892 |
52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96817678 |
53 | Amoebiasis_Homo sapiens_hsa05146 | 0.91741391 |
54 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91258243 |
55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89784492 |
56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88830896 |
57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85818852 |
58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84738543 |
59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84248971 |
60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84143667 |
61 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83769194 |
62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82961621 |
63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80549878 |
64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79971381 |
65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77887060 |
66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77710329 |
67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76720683 |
68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76428233 |
69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76319417 |
70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72935393 |
71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72861353 |
72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72399225 |
73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71065584 |
74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69959961 |
75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69426339 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68966387 |
77 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67666134 |
78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66801482 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66282701 |
80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65576161 |
81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62890738 |
82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62530594 |
83 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61894461 |
84 | Phototransduction_Homo sapiens_hsa04744 | 0.61878819 |
85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61775534 |
86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61682641 |
87 | Phagosome_Homo sapiens_hsa04145 | 0.61384993 |
88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60370359 |
89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59233209 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.59186230 |
91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58680747 |
92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58588492 |
93 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.57628927 |
94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57427135 |
95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57313506 |
96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57029377 |
97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56389654 |
98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56072391 |
99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55895771 |
100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54697087 |
101 | Pertussis_Homo sapiens_hsa05133 | 0.54543538 |
102 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54446728 |
103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54061104 |
104 | Malaria_Homo sapiens_hsa05144 | 0.53996859 |
105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53544675 |
106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53025018 |
107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51670782 |
108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51476573 |
109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50545219 |
110 | Prion diseases_Homo sapiens_hsa05020 | 0.50367904 |
111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49729282 |
112 | Alcoholism_Homo sapiens_hsa05034 | 0.49424164 |
113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47271773 |
114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46775771 |
115 | Bile secretion_Homo sapiens_hsa04976 | 0.46119584 |
116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45370625 |
117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45108371 |
118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42614141 |
119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42226094 |
120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41815157 |
121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41763645 |
122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41573878 |
123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40191088 |
124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35800685 |
125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35457038 |
126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34168884 |
127 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33951215 |
128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31627861 |
129 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31374581 |
130 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28986603 |